Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2009;120:278-285
Published online before print July 13, 2009, doi: 10.1161/CIRCULATIONAHA.109.853143
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
120/4/278    most recent
CIRCULATIONAHA.109.853143v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krahn, A. D.
Right arrow Articles by Gollob, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krahn, A. D.
Right arrow Articles by Gollob, M. H.
Related Collections
Right arrow Electrophysiology
Right arrow Clinical genetics
Right arrow Ablation/ICD/surgery
Right arrow CT and MRI
Right arrowRelated Article

(Circulation. 2009;120:278-285.)
© 2009 American Heart Association, Inc.


Arrhythmia/Electrophysiology

Systematic Assessment of Patients With Unexplained Cardiac Arrest

Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER)

Andrew D. Krahn, MD; Jeffrey S. Healey, MD; Vijay Chauhan, MD; David H. Birnie, MD; Christopher S. Simpson, MD; Jean Champagne, MD; Martin Gardner, MD; Shubhayan Sanatani, MD; Derek V. Exner, MD; George J. Klein, MD; Raymond Yee, MD; Allan C. Skanes, MD; Lorne J. Gula, MD; Michael H. Gollob, MD

From University of Western Ontario (A.D.K., G.J.K., R.Y., A.C.S., L.J.G.), London, Ontario, Canada; Hamilton Health Sciences Center (J.S.H.), Hamilton, Ontario, Canada; University Health Network (V.C.), Toronto, Ontario, Canada; University of Ottawa Heart Institute (D.H.B., M.H.G.), Ottawa, Ontario, Canada; Queen’s University (C.S.S.), Kingston, Ontario, Canada; Quebec Heart Institute (J.C.), Laval Hospital, Quebec City, Quebec, Canada; QEII Health Sciences Center (M.G.), Halifax, Nova Scotia, Canada; BC Children’s Hospital (S.S.), Vancouver, British Columbia, Canada; and Foothills Hospital (D.V.E.), Calgary, Alberta, Canada.

Correspondence to Dr Andrew Krahn, Arrhythmia Service, London Health Sciences Centre, 339 Windermere Rd, London, Ontario, Canada N6A 5A5. E-mail akrahn{at}uwo.ca

Received January 22, 2009; accepted May 6, 2009.

Background— Cardiac arrest without evident cardiac disease may be caused by subclinical genetic conditions. Provocative testing to unmask a phenotype is often necessary to detect primary electrical disease, direct genetic testing, and perform family screening.

Methods and Results— Patients with apparently unexplained cardiac arrest and no evident cardiac disease (normal cardiac function on echocardiogram, no evidence of coronary artery disease, and a normal ECG) underwent systematic evaluation that included cardiac magnetic resonance imaging, signal-averaged ECG, exercise testing, drug challenge, and selective electrophysiological testing. Diagnostic criteria were based on accepted criteria or provocation of the characteristic clinical features for long-QT syndrome, catecholaminergic polymorphic ventricular tachycardia, Brugada syndrome, early repolarization, arrhythmogenic right ventricular cardiomyopathy, coronary spasm, and myocarditis. Sixty-three patients in 9 centers were enrolled (age 43.0±13.4 years, 29 women). A diagnosis was obtained in 35 patients (56%): Long-QT syndrome in 8, catecholaminergic polymorphic ventricular tachycardia in 8, arrhythmogenic right ventricular cardiomyopathy in 6, early repolarization in 5, coronary spasm in 4, Brugada syndrome in 3, and myocarditis in 1. Targeted genetic testing demonstrated evidence of causative mutations in 9 (47%) of 19 patients. Screening of 64 family members of these patients identified 15 affected individuals who were treated (24%). The remaining 28 patients (44%) were considered to have idiopathic ventricular fibrillation.

Conclusions— Systematic clinical testing, including drug provocation and advanced imaging, results in unmasking of the cause of apparently unexplained cardiac arrest in >50% of patients. This approach assists in directing genetic testing to diagnose genetically mediated arrhythmia syndromes, which results in successful family screening.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2009 120: 267-268. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Journal Watch CardiologyHome page
Idiopathic Ventricular Fibrillation Is Becoming Less Idiopathic
Journal Watch Cardiology, September 2, 2009; 2009(902): 2 - 2.
[Full Text]